Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.

BMC cancer - 24 Feb 2011

Xu Bin, Tong Na, Chen Shu Q, Hua Li X, Wang Zeng J, Zhang Zheng D, Chen Ming

Abstract excerpt

BACKGROUND: Fibroblast growth factor receptor 4 (FGFR4) displays multiple biological activities, including mitogenic and angiogenic activity, and plays important roles in the etiology and progression of prostate cancer. Gly388Arg polymorphism in FGFR4 gene has been reported to be involved in prostate cancer incidence and aggressiveness in several studies. To derive a more precise estimation of the relationship, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Arginine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma

Share to Cell Transformation, Neoplastic

Share to Disease Progression

Share to Glycine

Share to Prostatic Neoplasms

Share to Receptor, Fibroblast Growth Factor, Type 4

Source

Open in PubMed Open full text

Identifiers

PMID: 21349172
DOI: 10.1186/1471-2407-11-84
PMCID: PMC3049742

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.PMID 21349172Read ↗

Association between fibroblast growth factor receptor-4 gene polymorphism and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.Semantic proximity Read ↗

New concept on association of FGFR4 G388R, V10I polymorphisms and risk of cancerSemantic proximity Read ↗

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.Semantic proximity Read ↗

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.Semantic proximity Read ↗

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.Semantic proximity Read ↗

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.Semantic proximity Read ↗

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.Semantic proximity Read ↗

The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.